Federal Circuit Boosts Impax In Aventis Patent Suit
A federal appeals court has given generic drug maker Impax Laboratories Inc. another chance to strike down a hotly contested patent for the Lou Gehrig's disease treatment held by rival Aventis...To view the full article, register now.
Already a subscriber? Click here to view full article